Ausgabe 1/2023
Inhalt (9 Artikel)
C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis
Xi Yao Gui, Simon W. Rabkin
Remote Monitoring of Cardiac Implantable Electronic Devices: What is the Evidence?
Adrian Reinhardt, Rodolfo Ventura
Heart Failure and Multimorbidity in Asia
Nathalie Ang, Chanchal Chandramouli, Kelvin Yiu, Claire Lawson, Jasper Tromp
What Is the Clinical Utility of Cardiac Troponins in Heart Failure? Are They Modifiable Beyond Their Prognostic Value?
David Agdashian, Lori B. Daniels
Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure
Alex Ritter, Cooper Quartermaine, Jovan Pierre-Charles, Suryakumar Balasubramanian, Pejman Raeisi-Giglou, Daniel Addison, Eric Miller
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
Giacomo Tini, Giuliano Tocci, Allegra Battistoni, Matteo Sarocchi, Camilla Pietrantoni, Domitilla Russo, Beatrice Musumeci, Carmine Savoia, Massimo Volpe, Paolo Spallarossa
Cardiac Involvement in Mitochondrial Disorders
Tudor-Alexandru Popoiu, Jan Dudek, Christoph Maack, Edoardo Bertero
Spot Urinary Sodium Measurements: the Future Direction of the Treatment and Follow-up of Patients with Heart Failure
Evelyne Meekers, Wilfried Mullens